Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11197)
All Articles published online
|
Publishing Process of This Article
|
Jun 21, 2014 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lonardo A, Adinolfi LE, Restivo L, Ballestri S, Romagnoli D, Baldelli E, Nascimbeni F, Loria P. Pathogenesis and significance of hepatitis C virus steatosis: An update on survival strategy of a successful pathogen. World J Gastroenterol 2014; 20(23): 7089-7103 [PMID: 24966582 DOI: 10.3748/wjg.v20.i23.7089] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i23/7089.htm |
| Number | Citing Articles |
| 1 |
Hend I. Shousha, Rasha A. Abdelaziz, Sherief M. Azab, Marwa Khairy, Shahira A. Afifi, Mai I. Mehrez, Mohamed A. Eshra, Ayman Y. Abdelrahim. Effect of treatment with direct acting antivirals on body mass index and hepatic steatosis in chronic hepatitis C. Journal of Medical Virology 2018; 90(6): 1099 doi: 10.1002/jmv.25062
|
| 2 |
Neda Nasheri, Zhibin Ning, Daniel Figeys, Shao Yao, Natalie K. Goto, John Paul Pezacki. Activity‐based profiling of the proteasome pathway during hepatitis C virus infection. PROTEOMICS 2015; 15(22): 3815 doi: 10.1002/pmic.201500169
|
| 3 |
Katsumi Iizuka. Dietary Interventions in Liver Disease. 2019; : 263 doi: 10.1016/B978-0-12-814466-4.00022-7
|
| 4 |
Yujin Ding, Guangdi Li, Zhiguang Zhou, Tuo Deng. Molecular mechanisms underlying hepatitis C virus infection-related diabetes. Metabolism 2021; 121: 154802 doi: 10.1016/j.metabol.2021.154802
|
| 5 |
Salvatore Petta. Hepatitis C virus and cardiovascular: A review. Journal of Advanced Research 2017; 8(2): 161 doi: 10.1016/j.jare.2016.06.001
|
| 6 |
Mark Benedict, Xuchen Zhang. Non-alcoholic fatty liver disease: An expanded review. World Journal of Hepatology 2017; 9(16): 715-732 doi: 10.4254/wjh.v9.i16.715
|
| 7 |
Dina G. Tiniakos, Quentin M. Anstee, Elizabeth M. Brunt, Alastair D. Burt. MacSween's Pathology of the Liver. 2024; : 330 doi: 10.1016/B978-0-7020-8228-3.00005-3
|
| 8 |
Jennifer C. Price, Yifei Ma, Rebecca Scherzer, Natalie Korn, Kyle Tillinghast, Marion G. Peters, Susan M. Noworolski, Phyllis C. Tien. Human immunodeficiency virus–infected and uninfected adults with non–genotype 3 hepatitis C virus have less hepatic steatosis than adults with neither infection. Hepatology 2017; 65(3): 853 doi: 10.1002/hep.28968
|
| 9 |
Thomas Pembroke, Marc Deschenes, Bertrand Lebouché, Amine Benmassaoud, Maida Sewitch, Peter Ghali, Philip Wong, Alex Halme, Elise Vuille-Lessard, Costa Pexos, Marina B. Klein, Giada Sebastiani. Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosis. Journal of Hepatology 2017; 67(4): 801 doi: 10.1016/j.jhep.2017.05.011
|
| 10 |
Luigi Adinolfi, Luca Rinaldi, Barbara Guerrera, Luciano Restivo, Aldo Marrone, Mauro Giordano, Rosa Zampino. NAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic Manifestations. International Journal of Molecular Sciences 2016; 17(6): 803 doi: 10.3390/ijms17060803
|
| 11 |
Elias Kouroumalis, Argyro Voumvouraki. Hepatitis C virus: A critical approach to who really needs treatment. World Journal of Hepatology 2022; 14(1): 1-44 doi: 10.4254/wjh.v14.i1.1
|
| 12 |
Amedeo Lonardo, Alessandro Mantovani. Clearing hepatitis C virus with direct antiviral agents reduces cardiovascular events in patients with prediabetes. Commentary to Sasso and colleagues. Nutrition, Metabolism and Cardiovascular Diseases 2021; 31(8): 2354 doi: 10.1016/j.numecd.2021.05.019
|
| 13 |
Ashraf O. Abdelaziz, Hend I. Shousha, Ebada M. Said, Zeinab A. Soliman, Ahmed A. Shehata, Mohamed M. Nabil, Ahmed H. Abdelmaksoud, Tamer M. Elbaz, Fatma M. Abdelsalam. Evaluation of liver steatosis, measured by controlled attenuation parameter, in patients with hepatitis C-induced advanced liver fibrosis and hepatocellular carcinoma. European Journal of Gastroenterology & Hepatology 2018; 30(11): 1384 doi: 10.1097/MEG.0000000000001196
|
| 14 |
Stefano Ciardullo, Alessandro Mantovani, Antonio Ciaccio, Marco Carbone, Pietro Invernizzi, Gianluca Perseghin. Hepatitis C virus infection and diabetes: A complex bidirectional relationship. Diabetes Research and Clinical Practice 2022; 187: 109870 doi: 10.1016/j.diabres.2022.109870
|
| 15 |
G. Targher, A. Lonardo, M. Rossini. Nonalcoholic fatty liver disease and decreased bone mineral density: is there a link?. Journal of Endocrinological Investigation 2015; 38(8): 817 doi: 10.1007/s40618-015-0315-6
|
| 16 |
Yanping Chen, Dan Cao, Chunyan Li, Pingping Zhang, Xiaoyun Wang, Na Li, Qunying Han, Zhengwen Liu. A nomogram for discrimination of non-alcoholic fatty liver disease in patients with chronic hepatitis B. European Journal of Gastroenterology & Hepatology 2021; 33(1): 69 doi: 10.1097/MEG.0000000000001691
|
| 17 |
Rahul Chaudhari, Sherouk Fouda, Ashik Sainu, Joseph M Pappachan. Metabolic complications of hepatitis C virus infection. World Journal of Gastroenterology 2021; 27(13): 1267-1282 doi: 10.3748/wjg.v27.i13.1267
|
| 18 |
Gehan S. Seifeldein, Elham A. Hassan, Hala M. Imam, Rania Makboul, Naglaa K. Idriss, Marwa A. Gaber, Reem M. Elkady. Quantitative MDCT and MRI assessment of hepatic steatosis in genotype 4 chronic hepatitis C patients with fibrosis. Egyptian Journal of Radiology and Nuclear Medicine 2021; 52(1) doi: 10.1186/s43055-021-00590-2
|
| 19 |
Amedeo Lonardo, Giovanni Targher. NAFLD: Is There Anything New under the Sun?. International Journal of Molecular Sciences 2017; 18(9): 1955 doi: 10.3390/ijms18091955
|
| 20 |
Yoshihiro Ikura. Transitions of histopathologic criteria for diagnosis of nonalcoholic fatty liver disease during the last three decades. World Journal of Hepatology 2014; 6(12): 894-900 doi: 10.4254/wjh.v6.i12.894
|
| 21 |
Anca Trifan, Ermina Stratina, Adrian Rotaru, Remus Stafie, Sebastian Zenovia, Robert Nastasa, Laura Huiban, Catalin Sfarti, Camelia Cojocariu, Tudor Cuciureanu, Cristina Muzica, Stefan Chiriac, Irina Girleanu, Ana-Maria Singeap, Carol Stanciu. Changes in Liver Steatosis Using Controlled Attenuation Parameter among Patients with Chronic Hepatitis C Infection Treated with Direct-Acting Antivirals Therapy Who Achieved Sustained Virological Response. Diagnostics 2022; 12(3): 702 doi: 10.3390/diagnostics12030702
|
| 22 |
Yingying Zhao, Huichun Xing. A Different Perspective for Management of Diabetes Mellitus: Controlling Viral Liver Diseases. Journal of Diabetes Research 2017; 2017: 1 doi: 10.1155/2017/5625371
|
| 23 |
Stefano Ballestri, Fabio Nascimbeni, Enrica Baldelli, Alessandra Marrazzo, Dante Romagnoli, Giovanni Targher, Amedeo Lonardo. Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseases. Metabolism 2017; 72: 57 doi: 10.1016/j.metabol.2017.04.003
|
| 24 |
Isabel Conde, Carmen Vinaixa, Marina Berenguer. Hepatitis C-related cirrhosis. Current status. Medicina Clínica (English Edition) 2017; 148(2): 78 doi: 10.1016/j.medcle.2016.09.035
|
| 25 |
Masaru Enomoto, Shuhei Nishiguchi, Akihiro Tamori, Ritsuzo Kozuka, Hideki Fujii, Sawako Uchida‐Kobayashi, Shinya Fukunishi, Yasuhiro Tsuda, Kazuhide Higuchi, Masaki Saito, Hirayuki Enomoto, Norifumi Kawada. Sequential therapy involving an early switch from entecavir to pegylated interferon‐α in Japanese patients with chronic hepatitis B. Hepatology Research 2018; 48(6): 459 doi: 10.1111/hepr.13050
|
| 26 |
Joseph L. Dempsey, George N. Ioannou, Rotonya M. Carr. Mechanisms of Lipid Droplet Accumulation in Steatotic Liver Diseases. Seminars in Liver Disease 2023; 43(04): 367 doi: 10.1055/a-2186-3557
|
| 27 |
|
| 28 |
Georg Semmler, Judith Stift, Bernhard Scheiner, Katharina Wöran, Philipp Schwabl, Rafael Paternostro, Theresa Bucsics, Albert Friedrich Stättermayer, Matthias Pinter, Arnulf Ferlitsch, Michael Trauner, Thomas Reiberger, Mattias Mandorfer. Performance of Controlled Attenuation Parameter in Patients with Advanced Chronic Liver Disease and Portal Hypertension. Digestive Diseases and Sciences 2019; 64(12): 3642 doi: 10.1007/s10620-019-05702-7
|
| 29 |
Zita Galvin, Ramraj Rajakumar, Emily Chen, Oyedele Adeyi, Markus Selzner, David Grant, Gonzalo Sapisochin, Paul Greig, Mark Cattral, Ian McGilvray, Anand Ghanekar, Nazia Selzner, Les Lilly, Keyur Patel, Mamatha Bhat. Predictors of De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation and Associated Fibrosis. Liver Transplantation 2019; 25(1): 56 doi: 10.1002/lt.25338
|
| 30 |
Annalisa Cespiati, Salvatore Petta, Rosa Lombardi, Vito Di Marco, Vincenza Calvaruso, Cristina Bertelli, Giuseppina Pisano, Erika Fatta, Giordano Sigon, Federica Iuculano, Luciano Crapanzano, Gerlando Gibilaro, Paolo Francione, Antonio Craxì, Silvia Fargion, Anna Ludovica Fracanzani. Metabolic comorbidities and male sex influence steatosis in chronic hepatitis C after viral eradication by direct-acting antiviral therapy (DAAs): Evaluation by the controlled attenuation parameter (CAP). Digestive and Liver Disease 2021; 53(10): 1301 doi: 10.1016/j.dld.2020.11.001
|
| 31 |
Daniel Clayton-Chubb, William Kemp, Ammar Majeed, John S. Lubel, Alex Hodge, Stuart K. Roberts. Understanding NAFLD: From Case Identification to Interventions, Outcomes, and Future Perspectives. Nutrients 2023; 15(3): 687 doi: 10.3390/nu15030687
|
| 32 |
Indian National Association for Study of the Liver (INASL) Guidance Paper on Nomenclature, Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease (NAFLD). Journal of Clinical and Experimental Hepatology 2023; 13(2): 273 doi: 10.1016/j.jceh.2022.11.014
|
| 33 |
Mauro Piacentini, Andrea Baiocchini, Franca Del Nonno, Gerry Melino, Nickolai A. Barlev, Federica Rossin, Manuela D’Eletto, Laura Falasca. Non-alcoholic fatty liver disease severity is modulated by transglutaminase type 2. Cell Death & Disease 2018; 9(3) doi: 10.1038/s41419-018-0292-8
|
| 34 |
Nathan J Shores, Maria Cássia Mendes-Corrêa, Ivana Maida, JoLyn Turner, Kevin P High, Sergio Babudieri, Marina Núñez. Hepatic peroxisome proliferator-activated receptor γ and α-mRNA expression in HCV-infected adults is decreased by HIV co-infection and is also affected by ethnicity. Clinics 2015; 70(12): 790 doi: 10.6061/clinics/2015(12)05
|
| 35 |
C Hamoir, Y Horsmans, P Stärkel, G Dahlqvist, S Negrin Dastis, N Lanthier. Risk of hepatocellular carcinoma and fibrosis evolution in hepatitis C patients with severe fibrosis or cirrhosis treated with direct acting antiviral agents. Acta Gastro Enterologica Belgica 2021; 84(1): 25 doi: 10.51821/84.1.420
|
| 36 |
Kamila Wójcik, Anna Piekarska, Alina Dąbrowicz, Marta Stasiak, Katarzyna Gawryś, Elżbieta Jabłonowska. Hepatic Expression of Phosphorylated Kinase Akt and Glycogen Synthase Kinase-3 Isoforms in Patients with Chronic Hepatitis C. Viral Immunology 2019; 32(4): 179 doi: 10.1089/vim.2018.0141
|
| 37 |
Daniela S. Allende, David E. Kleiner. Fatty liver disease that is neither metabolic nor alcoholic. Human Pathology 2023; 141: 212 doi: 10.1016/j.humpath.2023.01.003
|
| 38 |
Harleen K. Dyal, Maria Aguilar, Taft Bhuket, Benny Liu, Edward W. Holt, Sharon Torres, Ramsey Cheung, Robert J. Wong. Concurrent Obesity, Diabetes, and Steatosis Increase Risk of Advanced Fibrosis Among HCV Patients: A Systematic Review. Digestive Diseases and Sciences 2015; 60(9): 2813 doi: 10.1007/s10620-015-3760-3
|
| 39 |
Amedeo Lonardo, Stefano Ballestri, Giovanni Guaraldi, Fabio Nascimbeni, Dante Romagnoli, Stefano Zona, Giovanni Targher. Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV. World Journal of Gastroenterology 2016; 22(44): 9674-9693 doi: 10.3748/wjg.v22.i44.9674
|
| 40 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 2931 doi: 10.1007/978-3-319-26956-6_164
|
| 41 |
Daniel Ferguson, Jun Zhang, Matthew A. Davis, Robert N. Helsley, Lise-Lotte Vedin, Richard G. Lee, Rosanne M. Crooke, Mark J. Graham, Daniela S. Allende, Paolo Parini, J.Mark Brown. The lipid droplet-associated protein perilipin 3 facilitates hepatitis C virus-driven hepatic steatosis. Journal of Lipid Research 2017; 58(2): 420 doi: 10.1194/jlr.M073734
|
| 42 |
Anand Rattansingh, Hosein Amooshahi, Ravi J Menezes, Florence Wong, Sandra Fischer, Richard Kirsch, Mostafa Atri. Utility of shear‐wave elastography to differentiate low from advanced degrees of liver fibrosis in patients with hepatitis C virus infection of native and transplant livers. Journal of Clinical Ultrasound 2018; 46(5): 311 doi: 10.1002/jcu.22583
|
| 43 |
Yi-Hao Yen, Fang-Ying Kuo, Kwong-Ming Kee, Kuo-Chin Chang, Ming-Chao Tsai, Tsung-Hui Hu, Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, Chien-Hung Chen. Diabetes is associated with advanced fibrosis and fibrosis progression in non-genotype 3 chronic hepatitis C patients. Digestive and Liver Disease 2019; 51(1): 142 doi: 10.1016/j.dld.2018.07.003
|
| 44 |
Stefano Ballestri, Fabio Nascimbeni, Dante Romagnoli, Enrica Baldelli, Amedeo Lonardo. The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans. Advances in Therapy 2016; 33(3): 291 doi: 10.1007/s12325-016-0306-9
|
| 45 |
Giuseppe Indolfi, Maria Guido, Chiara Azzari, Massimo Resti. Histopathology of hepatitis C in children, a systematic review: implications for treatment. Expert Review of Anti-infective Therapy 2015; 13(10): 1225 doi: 10.1586/14787210.2015.1070668
|
| 46 |
Thomas Tu, Sandra Bühler, Ralf Bartenschlager. Chronic viral hepatitis and its association with liver cancer. Biological Chemistry 2017; 398(8): 817 doi: 10.1515/hsz-2017-0118
|
| 47 |
|
| 48 |
Sara Salehi Hammerstad, Shira Frankel Grock, Hanna J. Lee, Alia Hasham, Nina Sundaram, Yaron Tomer. Diabetes and Hepatitis C: A Two-Way Association. Frontiers in Endocrinology 2015; 6 doi: 10.3389/fendo.2015.00134
|
| 49 |
Viera Kupčová, Michaela Fedelešová, Jozef Bulas, Petra Kozmonová, Ladislav Turecký. Overview of the Pathogenesis, Genetic, and Non-Invasive Clinical, Biochemical, and Scoring Methods in the Assessment of NAFLD. International Journal of Environmental Research and Public Health 2019; 16(19): 3570 doi: 10.3390/ijerph16193570
|
| 50 |
Stefano Ballestri, Fabio Nascimbeni, Dante Romagnoli, Enrica Baldelli, Giovanni Targher, Amedeo Lonardo. Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection—Liver: The “Musketeer” in the Spotlight. International Journal of Molecular Sciences 2016; 17(3): 355 doi: 10.3390/ijms17030355
|
| 51 |
Dina G. Tiniakos, Quentin M. Anstee, Alastair D. Burt. Macsween's Pathology of the Liver. 2018; : 308 doi: 10.1016/B978-0-7020-6697-9.00005-4
|
| 52 |
J. Shah, E. Shao. Encyclopedia of Cardiovascular Research and Medicine. 2018; : 514 doi: 10.1016/B978-0-12-809657-4.11046-4
|
| 53 |
Isabel Conde, Carmen Vinaixa, Marina Berenguer. Cirrosis por hepatitis C. Estado actual. Medicina Clínica 2017; 148(2): 78 doi: 10.1016/j.medcli.2016.09.019
|
| 54 |
Thomas Karlas, Johanna Kollmeier, Stephan Böhm, Jürgen Müller, Peter Kovacs, Michael Tröltzsch, Antje Weimann, Michael Bartels, Jonas Rosendahl, Joachim Mössner, Thomas Berg, Volker Keim, Johannes Wiegand. Noninvasive characterization of graft steatosis after liver transplantation. Scandinavian Journal of Gastroenterology 2015; 50(2): 224 doi: 10.3109/00365521.2014.983156
|
| 55 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_164-1
|
| 56 |
Ester Vanni, Elisabetta Bugianesi, Giorgio Saracco. Treatment of type 2 diabetes mellitus by viral eradication in chronic hepatitis C: Myth or reality?. Digestive and Liver Disease 2016; 48(2): 105 doi: 10.1016/j.dld.2015.10.016
|
| 57 |
M. I. Valetskyi, M. U. Zak, O. V. Chernyshov, M. V. Sverdlova, V. S. Potochniak. Chronic Viral Hepatitis C: The Evolution of Scientific Views. Ukraïnsʹkij žurnal medicini, bìologìï ta sportu 2020; 5(5): 9 doi: 10.26693/jmbs05.05.009
|
| 58 |
Xiaoxia Wang, Yu Cao, Jia Guo, Dezhao Li, Haitao Zhang, Qingkun Song, Jun Lu. Association between MTTP genotype (-493G/T) polymorphism and hepatic steatosis in hepatitis C: a systematic review and meta-analysis. Lipids in Health and Disease 2023; 22(1) doi: 10.1186/s12944-023-01916-x
|
| 59 |
Shira Yair-Sabag, Elchanan Nussinson, Ofir Ben-Assuli, Fahmi Shibli, Azmi Shahbari, Shira Zelber-Sagi. Retrospective study of the associations between hepatitis C virus infection and metabolic factors. World Journal of Hepatology 2016; 8(30): 1269-1278 doi: 10.4254/wjh.v8.i30.1269
|
| 60 |
Hisamitsu Miyaaki, Tatsuki Ichikawa, Naota Taura, Satoshi Miuma, Takuya Honda, Hidetaka Shibata, Kan Toriyama, Kazuhiko Nakao. Significance of Hepatic Insulin Clearance in Patients with Chronic Hepatitis C and Non-alcoholic Fatty Liver Disease. Internal Medicine 2016; 55(9): 1049 doi: 10.2169/internalmedicine.55.5288
|
| 61 |
Catalina Mihai, Bogdan Mihai, Anca Trifan, Carol Stanciu, Liana Gheorghe, Mircea Diculescu, Manuela Curescu, Ciprian Brisc, Adrian Goldis, Simona Bataga, Larisa Sandulescu, Ion Rogoveanu, Andrada Seicean, Cristina Cijevschi Prelipcean. Metabolic Syndrome and Genotype 1 Virus C Compensated Liver Cirrhosis in the Era of Directly Acting Antiviral Therapy. Hepatitis Monthly 2017; 17(7) doi: 10.5812/hepatmon.58022
|
| 62 |
Caterina Sagnelli, Marco Merli, Caterina Uberti-Foppa, Hamid Hasson, Anna Grandone, Grazia Cirillo, Stefania Salpietro, Carmine Minichini, Mario Starace, Emanuela Messina, Patrizia Morelli, Emanuele Miraglia Del Giudice, Adriano Lazzarin, Nicola Coppola, Evangelista Sagnelli. TM6SF2 E167K variant predicts severe liver fibrosis for human immunodeficiency/hepatitis C virus co-infected patients, and severe steatosis only for a non-3 hepatitis C virus genotype. World Journal of Gastroenterology 2016; 22(38): 8509-8518 doi: 10.3748/wjg.v22.i38.8509
|
| 63 |
Kyoko Tsukiyama-Kohara, Michinori Kohara. Hepatitis C Virus: Viral Quasispecies and Genotypes. International Journal of Molecular Sciences 2017; 19(1): 23 doi: 10.3390/ijms19010023
|
| 64 |
Mona K. ElDeeb, Abeer A. Ghazal, Dalia E. Metwally, Lamya A. Elghlied. Possible roles of methylenetetrahydrofolate reductase polymorphism and folate status in patients with early hepatitis C virus genotype 4. Arab Journal of Gastroenterology 2021; 22(2): 121 doi: 10.1016/j.ajg.2020.12.001
|
| 65 |
Tatsuo Kanda, Mitsuhiko Moriyama. Direct-acting antiviral agents against hepatitis C virus and lipid metabolism. World Journal of Gastroenterology 2017; 23(31): 5645-5649 doi: 10.3748/wjg.v23.i31.5645
|
| 66 |
I. Valkov, R. Ivanova, C. Marinova, A. Alexiev, K. Antonov, D. Jelev, R. S. Ivanova, L. Mateva. A Comparative Analysis of Serum Lipids in Patients with Chronic Hepatitis C, Nonalcoholic Fatty Liver Disease and Healthy Controls. Acta Medica Bulgarica 2017; 44(1): 5 doi: 10.1515/amb-2017-0001
|
| 67 |
Monika Rau, Peter Buggisch, Stefan Mauss, Klaus H. W. Boeker, Hartwig Klinker, Tobias Müller, Albrecht Stoehr, Jörn M. Schattenberg, Andreas Geier, Pavel Strnad. Prognostic impact of steatosis in the clinical course of chronic HCV infection—Results from the German Hepatitis C-Registry. PLOS ONE 2022; 17(6): e0264741 doi: 10.1371/journal.pone.0264741
|
| 68 |
Valerie A. Villareal, Dan Fu, Deirdre A. Costello, Xiaoliang Sunney Xie, Priscilla L. Yang. Hepatitis C Virus Selectively Alters the Intracellular Localization of Desmosterol. ACS Chemical Biology 2016; 11(7): 1827 doi: 10.1021/acschembio.6b00324
|
| 69 |
Steven Roger, Alexandra Ducancelle, Hélène Le Guillou-Guillemette, Catherine Gaudy, Françoise Lunel. HCV virology and diagnosis. Clinics and Research in Hepatology and Gastroenterology 2021; 45(3): 101626 doi: 10.1016/j.clinre.2021.101626
|
| 70 |
Carolin Lackner. Practical Hepatic Pathology: a Diagnostic Approach. 2018; : 167 doi: 10.1016/B978-0-323-42873-6.00012-3
|
| 71 |
Phumelele Yvonne Siphepho, Yi-Ting Liu, Ciniso Sylvester Shabangu, Jee-Fu Huang, Chung-Feng Huang, Ming-Lun Yeh, Ming-Lung Yu, Shu-Chi Wang. The Impact of Steatosis on Chronic Hepatitis C Progression and Response to Antiviral Treatments. Biomedicines 2021; 9(10): 1491 doi: 10.3390/biomedicines9101491
|
| 72 |
Jamak Modaresi Esfeh, Kianoush Ansari-Gilani. Steatosis and hepatitis C. Gastroenterology Report 2015; : gov040 doi: 10.1093/gastro/gov040
|
| 73 |
Cordelia Manickam, Lynn Wachtman, Amanda J. Martinot, Luis D. Giavedoni, R. Keith Reeves, Gualtiero Alvisi. Metabolic Dysregulation in Hepacivirus Infection of Common Marmosets (Callithrix jacchus). PLOS ONE 2017; 12(1): e0170240 doi: 10.1371/journal.pone.0170240
|
| 74 |
D. Crisan, C. Radu, A. Suciu, N. Leach, H. Stefanescu, L. Avram, N. Crisan, M. Grigorescu. Hepatitis C in nonobese nondiabetic patients: Insulin resistance and the metabolic syndrome make a difference. Journal of Viral Hepatitis 2017; 24(1): 86 doi: 10.1111/jvh.12610
|